After the flood: BCG recall and ImmuCyst halt
This article was originally published in Scrip
Executive Summary
Following a flood at Sanofi Pasteur's Connaught Campus facility in Toronto last October, the company has issued a voluntary recall of its BCG vaccine in Canada, Australia and New Zealand. It has also halted all distribution of its BCG-based bladder cancer product ImmuCyst/TheraCys, which is manufactured in the same building and licensed in about 50 countries.